New York, NY, United States of America

Brittany Dubose

USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Brittany Dubose: Innovator in Genomic Research

Introduction

Brittany Dubose is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of genomic research, particularly in the area of neurodegenerative disorders. Her innovative work has led to the development of a unique patent that addresses critical challenges in genetic medicine.

Latest Patents

Brittany Dubose holds a patent for "Nuclease-mediated repeat expansion." This patent provides methods for expanding repeats already present at a genomic locus. It includes non-human animal genomes, non-human animal cells, and non-human animals that comprise a heterologous hexanucleotide repeat expansion sequence inserted at an endogenous C9orf72 locus. The patent also outlines methods for using these non-human animal cells or animals to identify therapeutic candidates that may prevent, delay, or treat neurodegenerative disorders associated with repeat expansion at the C9orf72 locus.

Career Highlights

Brittany is currently employed at Regeneron Pharmaceuticals, Inc., where she continues to advance her research in genomic medicine. Her work is pivotal in exploring new therapeutic avenues for treating complex genetic conditions.

Collaborations

Brittany collaborates with esteemed colleagues, including Daisuke Kajimura and Aarti Sharma-Kanning. These partnerships enhance her research efforts and contribute to the innovative environment at Regeneron Pharmaceuticals.

Conclusion

Brittany Dubose is a trailblazer in genomic research, with a focus on developing therapeutic solutions for neurodegenerative disorders. Her patent and ongoing work at Regeneron Pharmaceuticals exemplify her commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…